14,880 Shares in Haleon plc (NYSE:HLN) Acquired by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC acquired a new position in shares of Haleon plc (NYSE:HLN) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 14,880 shares of the company’s stock, valued at approximately $123,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Janney Montgomery Scott LLC grew its stake in Haleon by 182.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 438,833 shares of the company’s stock worth $3,726,000 after buying an additional 283,410 shares during the last quarter. Capstone Investment Advisors LLC acquired a new stake in Haleon in the first quarter valued at about $1,969,000. Wellington Management Group LLP boosted its stake in shares of Haleon by 164.6% in the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock valued at $111,454,000 after buying an additional 8,423,475 shares in the last quarter. Patrick M Sweeney & Associates Inc. purchased a new position in Haleon in the fourth quarter worth $1,083,000. Finally, Douglas Lane & Associates LLC boosted its position in shares of Haleon by 2.1% during the 1st quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock worth $71,332,000 after purchasing an additional 175,082 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HLN. Berenberg Bank initiated coverage on shares of Haleon in a research note on Wednesday, June 5th. They issued a “buy” rating for the company. HSBC assumed coverage on Haleon in a report on Wednesday, April 17th. They issued a “buy” rating on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Haleon presently has a consensus rating of “Moderate Buy”.

Haleon Trading Down 1.1 %

Shares of NYSE:HLN traded down $0.11 during trading on Monday, reaching $9.52. The stock had a trading volume of 4,745,791 shares, compared to its average volume of 5,220,244. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The stock has a market cap of $43.47 billion, a P/E ratio of 31.87, a PEG ratio of 2.69 and a beta of 0.24. The business has a fifty day moving average price of $8.65 and a 200-day moving average price of $8.43. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $9.73.

Haleon (NYSE:HLN) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The business had revenue of $3.50 billion for the quarter, compared to analysts’ expectations of $3.55 billion. Haleon had a return on equity of 19.85% and a net margin of 9.71%. During the same period in the prior year, the company earned $0.08 EPS. As a group, analysts anticipate that Haleon plc will post 0.47 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Stockholders of record on Friday, August 16th will be issued a dividend of $0.0514 per share. The ex-dividend date of this dividend is Friday, August 16th. This represents a dividend yield of 1.6%. Haleon’s payout ratio is currently 33.33%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.